Oil spikes after OPEC strikes first deal in 8 years
The price of Brent crude oil surged above $50 per barrel as rumours swirled that OPEC members had finally reached an agreement, which was later confirmed.
Author: Kristen McGachey
-
-
RBS stress test failure sends shares spiralling
Shares in RBS had fallen 5% top 187.2p by mid-morning on Wednesday after the bank emerged as the biggest failure in the Bank of England’s latest stress test scenario.
-
Long-term oil price rally a pipe dream – WisdomTree
WisdomTree research analyst Nick Leung has cautioned investors against the widespread optimism on a sustained oil price rally, suggesting the long-term pain of lower prices could continue.
-
FTSE 100 falters as Ofcom orders BT split
The index dipped by 0.53% to 6763 Tuesday morning as Ofcom launched formal proceedings to legally separate Openreach from BT Group.
-
Royal Mail shares tank after interim numbers fail to inspire
Markets were unimpressed by Royal Mail’s second consecutive quarter of meagre sales growth, dragging its shares down by 6.4% to 467.2p on Thursday morning.
-
Platform sales plummet to lowest point since RDR – Fundscape
Fund platform sales in the third quarter fell flat, despite decent asset growth among the top players, according to the latest Fundscape Platform Report.
-
FTSE 100 hoisted by Brexit-bruised Land Securities, easyJet and Vodafone
The FTSE 100 Index mirrored Monday morning’s rally and was up 0.8% at 6807 even after constituents Land Securities and Vodafone reported H1 losses and easyJet delivered lower profits Tuesday morning.
-
Hargreaves Lansdown ‘low-charge equity fund’ lands next month
Hargreaves Lansdown announced it will launch a new ‘low-charge’ equity fund on 1 December 2016.
-
Taylor Wimpey shares spike despite sales slip
Taylor Wimpey was among the top ten FTSE 100 risers Monday morning after it put out a trading update, rising by 3.7% to 151p per share.
-
Treasuries and cyclicals valuations stretched after Republican clean sweep – BAML
The outcome of the US election has triggered a largescale sell-off of bonds and splurges on cyclicals, according to data from Bank of America Merrill Lynch.
-
Are ESG funds doomed to fail under Trump?
President-elect Donald Trump might not be all bad for funds that make impactful investments in clean energy, technology or innovative pharmaceuticals, says AXA Investment Managers global head of responsible investment Matt Christensen.
-
AstraZeneca’s lower profits bitter pill to swallow
Shares were down 2.5% to 4,461.5p late Thursday morning, following reports the pharmaceutical group’s pre-tax profits had slipped 29%.
